Kalundborg, a small Danish city where Novo Nordisk produces Ozempic and Wegovy, has become a symbol of the global revolution of medicines for weight loss. The growth of pharmaceuticals has brought wealth, jobs and investment, but the recent fall in stocks, Eli Lilly's competition and redundancies raise doubts about the future of the city
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Kalundborg, a small Danish city where Novo Nordisk produces Ozempic and Wegovy, has become a symbol of the global revolution of medicines for weight loss. The growth of pharmaceuticals has brought wealth, jobs and investment, but the recent fall in stocks, Eli Lilly's competition and redundancies raise doubts about the future of the city